Sigma Planning’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-36,200
Closed -$1.33M – 1387
2020
Q4
$1.33M Buy
+36,200
New +$1.33M 0.05% 374

Other funds holding PFE

Sigma Planning's PFE Position: Q3 2026 in Review

Sigma Planning reduced its Pfizer (PFE) stake by 11% in Q3 2026, selling an estimated $598K and leaving 188,239 shares worth $5.37M. The position accounts for 0.14% of the portfolio, ranked #154.

Sigma Planning first reported a position in PFE in Q4 2014 and has held it in 48 quarters since. The position peaked at $15.1M in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Sigma Planning held 188,239 shares of Pfizer worth $5.37M as of Q3 2026.
  • Sigma Planning sold 22,496 Pfizer shares in Q3 2026, an estimated $598K.
  • Pfizer made up 0.14% of Sigma Planning's portfolio in Q3 2026, its #154 holding.
  • Sigma Planning first reported a position in Pfizer in Q4 2014 and has held it in 48 quarters since.
  • Sigma Planning's Pfizer position peaked at $15.1M in Q4 2021.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.